During the past decade, Morinomiya Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Morinomiya Hospital" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "C. R. Bard" with 1 trials sponsored, "Cook Group Incorporated" with 1 trials sponsored, "Cook Research Incorporated" with 1 trials sponsored and "Kyushu University" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Morinomiya Hospital" #1 collaborator was "Ain Shams University" with 1 trials as a collaborator, "Bard Ltd" with 1 trials as a collaborator, "Burke Rehabilitation Hospital" with 1 trials as a collaborator, "Burwood Hospital, Christchurch, New Zealand" with 1 trials as a collaborator and "Chonnam National University Hospital" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Morinomiya Hospital" are "Peripheral Arterial Disease" (2 trials), "Aortic Aneurysm" (1 trials), "Aortic Dissection" (1 trials), "Artery Diseases, Peripheral" (1 trials) and "Atherosclerosis" (1 trials). Many other conditions were trialed in "Morinomiya Hospital" in a lesser frequency.

Most popular intervention types in "Morinomiya Hospital" are "Device" (7 trials), "Drug" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Augmented activity feedback" (1 trials), "BioMimics 3D Vascular Stent System" (1 trials), "DVC1-0101" (1 trials), "ELUVIA (Stent Implantation)" (1 trials) and "Lutonix DCB" (1 trials). Other intervention names were less common.

The vast majority of trials in "Morinomiya Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Morinomiya Hospital". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Morinomiya Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Morinomiya Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".